# A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomized-non-comparative-phase-ii-study-of-anti-programmed-cell-death-ligand/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jean-Louis Pujol,Laurent Greillier,Clarisse Audigier-Valette,Denis Moro‐Sibilot,Lionel Uwer,J. Hureaux,Florian Guisier,D. Carmier,J. Madelaine,Josiane Otto,V. Gounant,P. Merle,Pierre Mourlanette,Olivier Molinier,Aldo Renault,Audrey Rabeau,Martine Antoine,Marc G. Denis,Sébastien Bommart,Alexandra Langlais,Franck Morin,Pierre-Jean Souquet |
| Citations | 182 |
| DOI | 10.1016/j.jtho.2019.01.008 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086419300255/pdf |
| OpenAlex ID | https://openalex.org/W2908914600 |
| PMID | 30664989 |
| Type | article |
| Year | 2019 |

## Paper authors

- [V. Gounant](https://scholariq.org/researchers/v-gounant/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.